Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan
· Delayed Price · Currency is TWD 78.80
-3.90 (-4.72%)
Apr 29, 2026, 12:19 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 5.51 billion as of April 28, 2026. Its market cap has increased by 337.44% in one year.
Market Cap
5.51B
Enterprise Value
5.08B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
78.80
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 5.51B, an increase of 145.99%. That is a compound annual growth rate of 52.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 5.51B | 37.60% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 5.81B |
| UnicoCell Biomed | 5.19B |
| Savior Lifetec | 5.93B |
| Panion & Bf Biotech | 5.98B |
| Mycenax Biotech | 6.03B |
| Sinphar Pharmaceutical | 6.04B |
| Pharmosa Biopharm | 4.96B |
| Medigen Biotechnology | 4.62B |